Clinical Trial: A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958861) titled 'A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis' on April 16.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of inhaled H057 in the treatment of acute exacerbations of bronchiectasis.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Acute Exacerbations of Bronchiectasis

Intervention: DRUG: inhaled H057

inhaled H057

DRUG: inhaled H057 placebo

inhaled H057 placebo

Recruitment Status:...